Fundraising Fox
/Companies
Sign in

Foment Bio

Montgomery, US · Founded 2023 · Delaware corporation

Find your way into Foment Bio

Sign up to see every warm intro you have to Foment Bio

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Foment Bio team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Foment Bio develops non-viral, off-the-shelf plasmid gene therapy constructs that trigger in vivo production of regenerative exosomes to restore tissue microvasculature, resolve inflammation, and prevent cell death. The therapy targets age-related and cardiometabolic chronic diseases including heart failure, chronic kidney disease, erectile dysfunction, and wound healing, and has advanced into FDA clinical trials.

BiotechHealthtechLongevity

Founders & leadership

BCBen Chlebina
Ben ChlebinaExecutive

Board

MPMarc Penn
Marc PennBoard director

Reported raises · per SEC filings

Form D private placements

$542.5K disclosed across 1 round · 2024

▶$542.5KraisedMar 2025 · 12 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Marc PennDirector
  • Ben ChlebinaExecutive Officer
Offering amount
$1M
Amount sold
$542.5K
Minimum investment
$10K
First sale
May 2024
Incorporated
Corporation, Delaware, 2023
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

elevatebioElevateBio is a contract development and manufacturing organization (CDMO) for advanced therapies, offering discovery, process development, analytics, manufacturing, and regulatory support for cell therapies, viral vectors, mRNA therapeutics, and gene editing. It partners with drug developers to bring cell and gene therapies from early discovery through commercial-scale cGMP manufacturing.

Companies working in the same space as Foment Bio.

Frequently asked questions

What does Foment Bio do?
Foment Bio develops non-viral, off-the-shelf plasmid gene therapy constructs that trigger in vivo production of regenerative exosomes to restore tissue microvasculature, resolve inflammation, and prevent cell death. The therapy targets age-related and cardiometabolic chronic diseases including heart failure, chronic kidney disease, erectile dysfunction, and wound healing, and has advanced into FDA clinical trials.
How much funding has Foment Bio raised?
Foment Bio has disclosed $542.5K raised across 1 round.
Where is Foment Bio headquartered?
Foment Bio is headquartered in Montgomery, US.